Invasive candidiasis in infants weighing more than 2500 grams at birth admitted to a neonatal intensive care unit

Pediatr Infect Dis J. 1996 Apr;15(4):348-52. doi: 10.1097/00006454-199604000-00013.

Abstract

Background: Because invasive candidiasis in newborn infants admitted to a neonatal intensive care unit (NICU) occurs most frequently in very low birth weight infants, the incidence of invasive candidiasis and its clinical features in infants > 2500 g birth weight have not been well-described.

Methods: We retrospectively reviewed the medical records of all infants with birth weight > 2500 g admitted to our NICU from 1986 through 1993 who developed invasive candidiasis during their hospitalization.

Results: Seventeen of 3033 (0.6%) infants with birth weights > 2500 g admitted to the NICU developed invasive candidiasis. All 17 infants had a condition that required prolonged NICU hospitalization; 13 of 17 (76%) had a major congenital malformation.

Conclusion: The incidence of invasive candidiasis in infants with birth weights > 2500 g requiring admission to a NICU was much less than has been reported for very low birth weight infants. This review points out that in infants with birth weights > 2500 g who develop invasive candidiasis, major congenital malformations are the most frequent underlying conditions responsible for prolonged NICU hospitalization.

MeSH terms

  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use
  • Birth Weight*
  • Candidiasis* / diagnosis
  • Candidiasis* / drug therapy
  • Candidiasis* / mortality
  • Congenital Abnormalities / microbiology
  • Female
  • Fluconazole / therapeutic use
  • Flucytosine / therapeutic use
  • Humans
  • Infant
  • Infant, Newborn
  • Intensive Care Units, Neonatal*
  • Male
  • Retrospective Studies

Substances

  • Antifungal Agents
  • Amphotericin B
  • Fluconazole
  • Flucytosine